D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 95 Citations 44,105 282 World Ranking 121 National Ranking 60
Medicine D-index 112 Citations 56,070 469 World Ranking 2266 National Ranking 1322

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

The scientist’s investigation covers issues in Immunology, Virology, Acquired immunodeficiency syndrome, Internal medicine and Viral load. His research in Immunology intersects with topics in Raltegravir, Pharmacotherapy and Semen. Joseph J. Eron combines subjects such as Viral disease, Asymptomatic and Blood plasma with his study of Acquired immunodeficiency syndrome.

The Internal medicine study combines topics in areas such as Gastroenterology and Surgery. His work investigates the relationship between Viral load and topics such as Rilpivirine that intersect with problems in Cabotegravir. His studies examine the connections between Lamivudine and genetics, as well as such issues in Reverse-transcriptase inhibitor, with regards to Nevirapine.

His most cited work include:

  • Prevention of HIV-1 Infection with Early Antiretroviral Therapy (5250 citations)
  • A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less (2365 citations)
  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)

What are the main themes of his work throughout his whole career to date?

Joseph J. Eron spends much of his time researching Internal medicine, Immunology, Virology, Viral load and Acquired immunodeficiency syndrome. His work deals with themes such as Gastroenterology and Lamivudine, which intersect with Internal medicine. In his study, Semen is strongly linked to Sexual transmission, which falls under the umbrella field of Immunology.

His study in Drug resistance extends to Virology with its themes. His Viral load research incorporates elements of RNA, Adverse effect, Pharmacotherapy and Emtricitabine, Antiretroviral therapy. His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Viral disease, Clinical trial, Immunopathology and Confidence interval.

He most often published in these fields:

  • Internal medicine (39.35%)
  • Immunology (30.42%)
  • Virology (27.19%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (39.35%)
  • Viral load (27.00%)
  • Antiretroviral therapy (9.70%)

In recent papers he was focusing on the following fields of study:

Joseph J. Eron focuses on Internal medicine, Viral load, Antiretroviral therapy, Cohort and Acquired immunodeficiency syndrome. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Tenofovir alafenamide and Emtricitabine. His research investigates the link between Viral load and topics such as Proportional hazards model that cross with problems in Stroke.

His biological study spans a wide range of topics, including Viremia, Immunology and Virology. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell, Adverse effect and In vivo. His Virology study combines topics from a wide range of disciplines, such as Drug resistance and Provirus.

Between 2018 and 2021, his most popular works were:

  • Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting (70 citations)
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. (45 citations)
  • Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies (40 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Cancer

Joseph J. Eron mainly focuses on Internal medicine, Acquired immunodeficiency syndrome, Antiretroviral therapy, Cohort and Viral load. Joseph J. Eron interconnects Tenofovir alafenamide, Cobicistat and Emtricitabine in the investigation of issues within Internal medicine. His studies deal with areas such as Observational study, Absolute risk reduction, Confidence interval, Regimen and Disease as well as Acquired immunodeficiency syndrome.

He has researched Antiretroviral therapy in several fields, including Viremia, Peripheral blood mononuclear cell, Intensive care medicine and Virology. His Viremia study is concerned with the larger field of Immunology. His Viral load study often links to related topics such as Young adult.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble.
The New England Journal of Medicine (2011)

7708 Citations

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

Scott M. Hammer;Kathleen E. Squires;Michael D. Hughes;Michael D. Hughes;Janet M. Grimes.
The New England Journal of Medicine (1997)

3125 Citations

Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy.
JAMA (2008)

2345 Citations

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

R M Gulick;J W Mellors;D Havlir;J J Eron.
The New England Journal of Medicine (1997)

2322 Citations

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Mari M. Kitahata;Stephen J. Gange;Alison G. Abraham;Barry Merriman.
The New England Journal of Medicine (2009)

1530 Citations

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner.
The New England Journal of Medicine (2003)

1133 Citations

Antiretroviral Therapy for the Prevention of HIV-1 Transmission

Myron S. Cohen;Ying Q. Chen;Marybeth McCauley;Theresa Gamble.
The New England Journal of Medicine (2016)

1113 Citations

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1

Myron S Cohen;Irving F Hoffman;Rachel A Royce;Peter Kazembe.
The Lancet (1997)

1052 Citations

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy

N. M. Archin;A. L. Liberty;A. D. Kashuba;S. K. Choudhary.
Nature (2012)

995 Citations

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

Christopher D. Pilcher;Hsiao Chuan Tien;Joseph J. Eron;Pietro L. Vernazza.
The Journal of Infectious Diseases (2004)

875 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Joseph J. Eron

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 351

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 344

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 219

Robert F. Siliciano

Robert F. Siliciano

Johns Hopkins University School of Medicine

Publications: 197

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 188

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 176

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 172

Myron S. Cohen

Myron S. Cohen

University of North Carolina at Chapel Hill

Publications: 167

Georgia D. Tomaras

Georgia D. Tomaras

Duke University

Publications: 160

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 157

David A. Cooper

David A. Cooper

Pfizer (United States)

Publications: 151

David C. Montefiori

David C. Montefiori

Duke University

Publications: 149

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 147

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 143

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 143

Amy C. Justice

Amy C. Justice

Yale University

Publications: 137

Something went wrong. Please try again later.